Made in India Heart-Lung Machine Set to Challenge Imports

India’s heart-lung machine market is set for a major shift as a homegrown device gains key regulatory approvals.

The heart-lung machine developed by Mediyant Technologies has received USFDA 510(k) clearance and CDSCO approval.

The device is called the New Century Heart-Lung Machine. It is designed for use during open-heart surgeries. The machine supports blood circulation and oxygenation when the heart and lungs are temporarily stopped.

Homegrown Device Gets Key Regulatory Approvals

Mediyant Technologies developed the device after years of work on indigenous cardiac care technology. The company has secured approval to manufacture and market the machine in India.

The device has also received USFDA 510(k) clearance. This approval allows the company to market the device in the United States.

The approvals could strengthen India’s position in the medical device manufacturing sector. They may also help reduce dependence on imported cardiac equipment.

Key points include:

• Developed by India-based Mediyant Technologies.
• Received USFDA 510(k) clearance.
• Secured a Class C manufacturing license from CDSCO.
• Designed for use during open-heart procedures.
• The company is preparing to scale production.
• Mediyant has also secured export orders for the US market.

Also Read: Why Vaccine Innovation Must Go Beyond Traditional Platforms

Mediyant Targets India and Global Markets

The company plans to increase production as demand grows. Its USFDA clearance could also open opportunities in other international markets. Heart-lung machines are critical equipment in cardiac surgery. They temporarily take over the functions of the heart and lungs during certain procedures.

India has traditionally depended on imported medical devices for several complex healthcare applications. Local production could help address this gap. The development also supports the broader push for medical device manufacturing in India. Government policies have encouraged companies to build advanced healthcare equipment locally.

Mediyant’s device could compete with imported heart-lung machines if production expands. Cost, availability, service support, and clinical acceptance will remain important factors.

A Step Toward Greater Medical Device Self-Reliance

The regulatory clearances mark an important step for India’s indigenous medical technology sector. The company now has a pathway to serve both domestic and international customers. USFDA clearance may also improve the device’s credibility among overseas buyers.

Export orders indicate early interest in the product outside India. As Mediyant scales production, the machine could support India’s efforts to build a stronger domestic medical device ecosystem. It could also create opportunities for further innovation in cardiac care equipment.